MedTrace Logo

Home and Community Use of a Suspension Walker in Pre-Walking Infants With Down Syndrome

NCT07631130 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2026-06-05

No results posted yet for this study

Summary

The goal of this clinical trial is to learn if pre-walking infants with Down syndrome can use a suspension walker in their home and community environments. The main questions it aims to answer are:

* Is suspension walker intervention feasible for pre-walking infants with Down syndrome?
* What are barriers to successfully using suspension walkers in home and community environments?
* What are facilitators for successfully using suspension walkers in home and community environments?

Participants will:

* Use a suspension walker in the home and community for a three-month period (goal 20 minutes/day, 5 days/week)
* Meet with a therapist three times in their home to learn how to use the walker
* Track how often they use the walker for one week each month
* Complete assessments of infants' gross motor skill and ability to use the walker before and after the three-month period
* Be interviewed after the three-month period about their experiences using the walker

Conditions

Interventions

BEHAVIORAL

suspension walker

Parents will be provided with a pediatric suspension walker and instructed to use the walker with their infant at least 20 total min/day, 5 days/week. Parents will be instructed in 3 activity types: 1) Adult-propelled stepping consists of the caregiver moving the walker along the floor to prompt the infant to step. 2) Self-propelled walking consists of encouraging the infant to step independently to propel the walker, with intermittent assistance from the caregiver as needed. 3) Play consists of a variety of mobile and stationary play activities, adapted to the child's interests, engaged in while supported in the walker. Parents will brainstorm with the therapist to select play activities and to determine where and when to perform stepping and walking activities. This may include home- and community-based locations, including larger rooms in the home, hallways, sidewalks, parks, and indoor community spaces like supermarkets or shopping malls.

Sponsors & Collaborators

  • University of Southern California

    lead OTHER

Principal Investigators

  • Kari S Kretch, PT, DPT, PhD · University of Southern California

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
10 Months
Max Age
13 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-09-30
Primary Completion
2028-08-31
Completion
2028-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07631130 on ClinicalTrials.gov